The application of clinical genetics: editorial
The Application of Clinical Genetics Martin H MaurerDepartment of Physiology and Pathophysiology, University of Heidelberg, Heidelberg, Germany; Mariaberg Hospital for Child and Adolescent Psychiatry, Gammertingen, GermanyIn 2012, The Application of Clinical Genetics enters its fifth year of publica...
Saved in:
| Main Author: | |
|---|---|
| Format: | Article (Journal) Editorial |
| Language: | English |
| Published: |
23 February 2012
|
| In: |
The application of clinical genetics
Year: 2012, Volume: 5, Pages: 19-20 |
| ISSN: | 1178-704X |
| DOI: | 10.2147/TACG.S30150 |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.2147/TACG.S30150 Verlag, lizenzpflichtig, Volltext: https://www.dovepress.com/the-application-of-clinical-genetics-peer-reviewed-fulltext-article-TACG 
|
| Author Notes: | Martin H. Maurer |
| Summary: | The Application of Clinical Genetics Martin H MaurerDepartment of Physiology and Pathophysiology, University of Heidelberg, Heidelberg, Germany; Mariaberg Hospital for Child and Adolescent Psychiatry, Gammertingen, GermanyIn 2012, The Application of Clinical Genetics enters its fifth year of publication. The journal has had a change of Editor-in-Chief: Dr David H Tegay stepped down and I was appointed to serve as the new Editor-in-Chief. As his successor, I thank Dr Tegay for his great work for the journal. I hope I can continue his successful editorial contributions. Moreover, I thank the many reviewers for their sustained support of the journal.The Application of Clinical Genetics is dedicated to open access publishing – as all Dove Press journals are. This means that authors will be charged for the publication process, but the acceptance of a manuscript is based solely on its scientific quality. This is what I will be responsible for as Editor-in-Chief. The team at Dove Press is a constant help with all administrative duties concerning peer reviewal, and I want to express my thanks for their prompt and reliable help. The field of clinical genetics is facing new challenges with the broad availability of large-scale screening methods for gene mutations, such as high-throughput sequencing and biochips. This means that ethical issues regarding the handling of genetic information must be addressed, both for the individual and for society.1–3 For example, sequencing of cell-free, fetal nucleic acids in the maternal blood to locate fetal aneuploidy, especially trisomy 21, may become broadly available soon, with even faster results than conventional methods such as amniocentesis. |
|---|---|
| Item Description: | Gesehen am 22.04.2024 |
| Physical Description: | Online Resource |
| ISSN: | 1178-704X |
| DOI: | 10.2147/TACG.S30150 |